Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues

Glendon M. Zinser; Mark Suckow; Jo Ellen Welsh

doi:10.1016/j.jsbmb.2005.06.024

Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues

Glendon M. Zinser, Mark Suckow, Jo Ellen Welsh

Research output: Contribution to journal › Article › peer-review

122 Scopus citations

Abstract

The Vitamin D receptor (VDR) and its ligand, 1,25(OH)₂D ₃, regulate cell proliferation, differentiation and apoptosis in vitro, yet the physiological significance of this regulation is unclear. In these studies, we used VDR knockout (VDRKO) mice to examine the impact of VDR on chemical carcinogen-induced tumorigenesis in vivo. Wild type (WT) and VDRKO littermates were fed a high calcium diet to prevent disturbances in calcium homeostasis and were gavaged with dimethylbenzanthracence (DMBA) using a protocol designed to induce mammary tumors. Compared to WT littermates, VDRKO mice exhibited an increased incidence of mammary gland hyperplasia and a higher percentage of hormone independent tumors with squamous differentiation. VDR ablation also significantly enhanced tumor development in epidermis and lymphoid tissues, but did not affect tumor development in ovary, uterus, lung or liver. These data indicate that VDR ablation alters susceptibility to DMBA-induced carcinogenesis in a tissue specific fashion, and provide support that optimal VDR signaling may act to suppress tumorigenesis.

Original language	English
Pages (from-to)	153-164
Number of pages	12
Journal	Journal of Steroid Biochemistry and Molecular Biology
Volume	97
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jsbmb.2005.06.024
State	Published - Oct 2005

Bibliographical note

Funding Information:
This research was supported by grants to JW from the National Institutes of Health (CA69700) and a Dissertation award to GMZ from the Susan G. Komen Breast Cancer Foundation (DISS 0100302). The authors are grateful to Emily Tribble for her assistance with tissue processing and histology, and to Valerie Schroeder and Lindsay Barnett of the Freimann Life Science Center at the University of Notre Dame for care of the animal colonies. Histopathological assessment of mammary tumors by Dr. Robert Cardiff at the UC Davis Mutant Mouse Resource is greatly appreciated.

Funding

This research was supported by grants to JW from the National Institutes of Health (CA69700) and a Dissertation award to GMZ from the Susan G. Komen Breast Cancer Foundation (DISS 0100302). The authors are grateful to Emily Tribble for her assistance with tissue processing and histology, and to Valerie Schroeder and Lindsay Barnett of the Freimann Life Science Center at the University of Notre Dame for care of the animal colonies. Histopathological assessment of mammary tumors by Dr. Robert Cardiff at the UC Davis Mutant Mouse Resource is greatly appreciated.

Funders	Funder number
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer Institute	R01CA069700
Susan G Komen Foundation	DISS 0100302

Keywords

Breast cancer
DMBA
Mammary
Vitamin D receptor

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Biochemistry
Molecular Medicine
Molecular Biology
Endocrinology
Clinical Biochemistry
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jsbmb.2005.06.024

Cite this

@article{d17e18b5b52642cab04f04ca5bf20322,

title = "Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues",

abstract = "The Vitamin D receptor (VDR) and its ligand, 1,25(OH)2D 3, regulate cell proliferation, differentiation and apoptosis in vitro, yet the physiological significance of this regulation is unclear. In these studies, we used VDR knockout (VDRKO) mice to examine the impact of VDR on chemical carcinogen-induced tumorigenesis in vivo. Wild type (WT) and VDRKO littermates were fed a high calcium diet to prevent disturbances in calcium homeostasis and were gavaged with dimethylbenzanthracence (DMBA) using a protocol designed to induce mammary tumors. Compared to WT littermates, VDRKO mice exhibited an increased incidence of mammary gland hyperplasia and a higher percentage of hormone independent tumors with squamous differentiation. VDR ablation also significantly enhanced tumor development in epidermis and lymphoid tissues, but did not affect tumor development in ovary, uterus, lung or liver. These data indicate that VDR ablation alters susceptibility to DMBA-induced carcinogenesis in a tissue specific fashion, and provide support that optimal VDR signaling may act to suppress tumorigenesis.",

keywords = "Breast cancer, DMBA, Mammary, Vitamin D receptor",

author = "Zinser, {Glendon M.} and Mark Suckow and Welsh, {Jo Ellen}",

note = "Funding Information: This research was supported by grants to JW from the National Institutes of Health (CA69700) and a Dissertation award to GMZ from the Susan G. Komen Breast Cancer Foundation (DISS 0100302). The authors are grateful to Emily Tribble for her assistance with tissue processing and histology, and to Valerie Schroeder and Lindsay Barnett of the Freimann Life Science Center at the University of Notre Dame for care of the animal colonies. Histopathological assessment of mammary tumors by Dr. Robert Cardiff at the UC Davis Mutant Mouse Resource is greatly appreciated.",

year = "2005",

month = oct,

doi = "10.1016/j.jsbmb.2005.06.024",

language = "English",

volume = "97",

pages = "153--164",

number = "1-2",

}

TY - JOUR

T1 - Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues

AU - Zinser, Glendon M.

AU - Suckow, Mark

AU - Welsh, Jo Ellen

N1 - Funding Information: This research was supported by grants to JW from the National Institutes of Health (CA69700) and a Dissertation award to GMZ from the Susan G. Komen Breast Cancer Foundation (DISS 0100302). The authors are grateful to Emily Tribble for her assistance with tissue processing and histology, and to Valerie Schroeder and Lindsay Barnett of the Freimann Life Science Center at the University of Notre Dame for care of the animal colonies. Histopathological assessment of mammary tumors by Dr. Robert Cardiff at the UC Davis Mutant Mouse Resource is greatly appreciated.

PY - 2005/10

Y1 - 2005/10

N2 - The Vitamin D receptor (VDR) and its ligand, 1,25(OH)2D 3, regulate cell proliferation, differentiation and apoptosis in vitro, yet the physiological significance of this regulation is unclear. In these studies, we used VDR knockout (VDRKO) mice to examine the impact of VDR on chemical carcinogen-induced tumorigenesis in vivo. Wild type (WT) and VDRKO littermates were fed a high calcium diet to prevent disturbances in calcium homeostasis and were gavaged with dimethylbenzanthracence (DMBA) using a protocol designed to induce mammary tumors. Compared to WT littermates, VDRKO mice exhibited an increased incidence of mammary gland hyperplasia and a higher percentage of hormone independent tumors with squamous differentiation. VDR ablation also significantly enhanced tumor development in epidermis and lymphoid tissues, but did not affect tumor development in ovary, uterus, lung or liver. These data indicate that VDR ablation alters susceptibility to DMBA-induced carcinogenesis in a tissue specific fashion, and provide support that optimal VDR signaling may act to suppress tumorigenesis.

AB - The Vitamin D receptor (VDR) and its ligand, 1,25(OH)2D 3, regulate cell proliferation, differentiation and apoptosis in vitro, yet the physiological significance of this regulation is unclear. In these studies, we used VDR knockout (VDRKO) mice to examine the impact of VDR on chemical carcinogen-induced tumorigenesis in vivo. Wild type (WT) and VDRKO littermates were fed a high calcium diet to prevent disturbances in calcium homeostasis and were gavaged with dimethylbenzanthracence (DMBA) using a protocol designed to induce mammary tumors. Compared to WT littermates, VDRKO mice exhibited an increased incidence of mammary gland hyperplasia and a higher percentage of hormone independent tumors with squamous differentiation. VDR ablation also significantly enhanced tumor development in epidermis and lymphoid tissues, but did not affect tumor development in ovary, uterus, lung or liver. These data indicate that VDR ablation alters susceptibility to DMBA-induced carcinogenesis in a tissue specific fashion, and provide support that optimal VDR signaling may act to suppress tumorigenesis.

KW - Breast cancer

KW - DMBA

KW - Mammary

KW - Vitamin D receptor

UR - http://www.scopus.com/inward/record.url?scp=27544513984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544513984&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2005.06.024

DO - 10.1016/j.jsbmb.2005.06.024

M3 - Article

C2 - 16111884

AN - SCOPUS:27544513984

SN - 0960-0760

VL - 97

SP - 153

EP - 164

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

IS - 1-2

ER -

Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this